Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...

A lab in Hawaiʻi is developing nanobodies, tiny proteins that help the immune system recognize and destroy cancer cells, ...

Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...

Genomics-guided trial could increase options for people undergoing cancer therapy — plus, a landmark ancient-genome study ...

Regeneron Pharmaceuticals plans to expand its pipeline into radiopharmaceutical therapies through an up to $4.3 billion collaboration with Telix Pharmaceuticals to co-develop and co-commercialize ...

Worth up to $300 million, the buyout is Lilly’s latest of an ADC maker and adds technology for making “dual-payload” ...

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases.

Patients with elevated anti-HLA antibodies experienced significantly prolonged time to transplant — a median of 120 days ...